Genetic and transcriptional evolution alters cancer cell line drug response
2018 · Nature · 890 citations
https://doi.org/10.1038/s41586-018-0409-3
A
Aaron R. Thorner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
279
Papers
12.7K
Citations
50
h-index
78
i10-index
Aaron R. Thorner is an academic researcher from Dana-Farber Cancer Institute. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Sarcoma Diagnosis and Treatment & Renal cell carcinoma treatment. The author has an h-index of 50, co-authored 238 publications.
ORCID: 0000-0002-9160-7881Papers by this author
worksCas9 activates the p53 pathway and selects for p53-inactivating mutations
2020 · Nature Genetics · 278 citations
https://doi.org/10.1038/s41588-020-0623-4
Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing
2018 · BMC Genomics · 235 citations
https://doi.org/10.1186/s12864-017-4428-5
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group
2018 · British Journal of Cancer · 131 citations
https://doi.org/10.1038/s41416-018-0212-9
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma
2020 · Genome Medicine · 115 citations
https://doi.org/10.1186/s13073-020-00727-4
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
2018 · Nature Communications · 111 citations
https://doi.org/10.1038/s41467-018-04356-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat